RPG Life Sciences has reported results for the second quarter ended September 30, 2013.
The company has a jump of over seven fold in its net profit at Rs 2.24 crore for the quarter as compared to Rs 0.31 crore for the same quarter in the previous year. Total income from operation of the company has increased by 5.62% at Rs 61.61 crore for quarter under review as compared to Rs 58.33 crore for the quarter ended September 30, 2012.
RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space.